Correction: Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals.

Autor: El-Shenawy R; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt., Moustafa RI; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt.; School of Pharmacy, Newgiza University (NGU), Newgiza, 12577, Giza, Egypt., Helmy NM; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt., El-Abd YS; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt., Tabll AA; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt.; Egypt Center for Research and Regenerative Medicine (ECRRM), Cairo, Egypt., Elesnawy YK; National Committee for Control of Viral Hepatitis (NCCVH), Ministry of Health and Population, Cairo, Egypt., Shawky H; Therapeutic Chemistry Department, Pharmaceutical Industries and Drug Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt. hs.tohami@nrc.sci.eg.

Publikováno v: Virology journal [Virol J] 2024 Dec 12; Vol. 21 (1), pp. 317. Date of Electronic Publication: 2024 Dec 12.

Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia.

Autor: Shawky H; Therapeutic Chemistry Department, Pharmaceutical Industries and Drug Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt., Tabll AA; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt., Elshenawy RM; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt., Helmy NM; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt., Moustafa RI; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt., Elesnawy YK; Ahmed Maher Teaching Hospital, Cairo, Egypt., Abdelghany MM; National Committee for Control of Viral Hepatitis (NCCVH), Ministry of Health and Population, Cairo, Egypt., El-Abd YS; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt. ys.el-abd@nrc.sci.eg.

Publikováno v: Microbial cell factories [Microb Cell Fact] 2024 Jan 18; Vol. 23 (1), pp. 25. Date of Electronic Publication: 2024 Jan 18.